What is the Direction of New Targets? Different Target Identification Strategies

• Reviewing the state of play of target identification and validation, and business rationale to explore newly discovered targets
• Leveraging human genetic data to understand the efficacy of new drugs
• Discussing the optimal moment for a biotech to partner a novel target identified through an innovative platform and whether the current deal-making landscape is favouring first-in-class or best-in-class

Speakers:

Alice Zhang

Chief Executive Officer & Co-founder

Verge Genomics

Martin Jacko

Founder & Chief Executive Officer

Aperture Therapeutics

Alexey Kadet

Chief Business Officer

Crownlands

Heiko Wurdak

Co-Founder, Chief Scientific Officer

Assemblify